Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma

• Auteurs principaux: Faiena I (Auteur), Cummings AL (Auteur), Crosetti AM (Auteur), Pantuck AJ (Auteur), Chamie K (Auteur), Drakaki A (Auteur)
• Format: Livre
• Publié: Dove Medical Press, 2018-01-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Izak Faiena,1,2 Amy L Cummings,3 Anna M Crosetti,3 Allan J Pantuck,1,2 Karim Chamie,1,2 Alexandra Drakaki1–3 1Department of Urology, 2Institute of Urologic Oncology, 3Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at University of California, L...